Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7855-7864

  Secher, Thomas ^a   Vasseur, Virginie ^a   Poisson, Didier Marc ^b   Mitchell, Jane A ^c   Cunha, Fernando Q ^d   Alves Filho, José Carlos ^e   Ryffel, Bernhard ^a,f  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b Orleans Regional Hospital   (France)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; ETANERCEPT; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DISEASE CONTROL; EXPERIENCE; IMMUNE RESPONSE; INFLAMMATION; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTECTION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SEPSIS; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PERITONITIS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PERITONITIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 67649201746     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804008     Document Type: Article

References (64)

1. Holzheimer, R. G., K. H. Muhrer, N. L'Allemand, T. Schmidt, and K. Henneking. 1991. Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection 19: 447-452.
2. Guidet, B., P. Aegerter, R. Gauzit, P. Meshaka, and D. Dreyfuss. 2005. Incidence and impact of organ dysfunctions associated with sepsis. Chest 127: 942-951.
3. Eggimann, P., and D. Pittet. 2001. Infection control in the ICU. Chest 120: 2059-2093.
4. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
5. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474.
6. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452.
7. Sedgwick, J. D., D. S. Riminton, J. G. Cyster, and H. Korner. 2000. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol. Today 21: 110-113.
8. Ruuls, S. R., R. M. Hoek, V. N. Ngo, T. McNeil, L. A. Lucian, M. J. Janatpour, H. Korner, H. Scheerens, E. M. Hessel, J. G. Cyster, et al. 2001. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15: 533-543.
9. Kinkhabwala, M., P. Sehajpal, E. Skolnik, D. Smith, V. K. Sharma, H. Vlassara, A. Cerami, and M. Suthanthiran. 1990. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J. Exp. Med. 171: 941-946.
10. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
11. Wilhelm, P., F. Wiede, A. Meissner, N. Donhauser, C. Bogdan, and H. Korner. 2005. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes Infect. 7: 1461-1468.
12. Virna, S., M. Deckert, S. Lutjen, S. Soltek, K. E. Foulds, H. Shen, H. Korner, J. D. Sedgwick, and D. Schluter. 2006. TNF is important for pathogen control and limits brain damage in murine cerebral listeriosis. J. Immunol. 177: 3972-3982.
13. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
14. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-871. (Pubitemid 16246587)
15. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664.
16. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
17. Garcia, I., Y. Miyazaki, K. Araki, M. Araki, R. Lucas, G. E. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, et al. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25: 2401-2407.
18. Zantl, N., A. Uebe, B. Neumann, H. Wagner, J. R. Siewert, B. Holzmann, C. D. Heidecke, and K. Pfeffer. 1998. Essential role of γ interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect. Immun. 66: 2300-2309.
19. Singleton, K. D., and P. E. Wischmeyer. 2003. Distance of cecum ligated influences mortality, tumor necrosis factor-α and interleukin-6 expression following cecal ligation and puncture in the rat. Eur. Surg. Res. 35: 486-491.
20. Ebach, D. R., T. E. Riehl, and W. F. Stenson. 2005. Opposing effects of tumor necrosis factor receptor 1 and 2 in sepsis due to cecal ligation and puncture. Shock 23: 311-318.
21. Aderka, D., A. Wysenbeek, H. Engelmann, A. P. Cope, F. Brennan, Y. Molad, V. Hornik, Y. Levo, R. N. Maini, M. Feldmann, et al. 1993. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum. 36: 1111-1120.
22. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89: 4845-4849.
23. Warren, H. S. 1997. Strategies for the treatment of sepsis. N. Engl. J. Med. 336: 952-953.
24. Wagner, J. G., and R. A. Roth. 1999. Neutrophil migration during endotoxemia. J. Leukocyte Biol. 66: 10-24.
25. Segal, A. W. 2005. How neutrophils kill microbes. Annu. Rev. Immunol. 23: 197-223.
26. Feldmann, M., F. M. Brennan, E. Paleolog, A. Cope, P. Taylor, R. Williams, J. Woody, and R. N. Maini. 2004. Anti-TNFα therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found. Symp. 256: 53-69.
27. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802.
28. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560-563.
29. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098.
30. Annane, D., E. Bellissant, and J. M. Cavaillon. 2005. Septic shock. Lancet 365: 63-78.
31. Torossian, A., S. Ruehlmann, M. Middeke, D. I. Sessler, W. Lorenz, H. F. Wulf, and A. Bauhofer. 2004. Mild preseptic hypothermia is detrimental in rats. Crit. Care Med. 32: 1899-1903.
32. Garcia-Ramallo, E., T. Marques, N. Prats, J. Beleta, S. L. Kunkel, and N. Godessart. 2002. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J. Immunol. 169: 6467-6473. (Pubitemid 36903497)
33. Lau, D., H. Mollnau, J. P. Eiserich, B. A. Freeman, A. Daiber, U. M. Gehling, J. Brummer, V. Rudolph, T. Munzel, T. Heitzer, et al. 2005. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc. Natl. Acad. Sci. USA 102: 431-436.
34. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
35. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. The enigma of sepsis. J. Clin. Invest. 112: 460-467.
36. Alves-Filho, J. C., B. M. Tavares-Murta, C. Barja-Fidalgo, C. F. Benjamim, A. Basile-Filho, S. M. Arraes, and F. Q. Cunha. 2006. Neutrophil function in severe sepsis. Endocr. Metab. Immune Disord. Drug Targets 6: 151-158.
37. Rios-Santos, F., J. C. Alves-Filho, F. O. Souto, F. Spiller, A. Freitas, C. M. Lotufo, M. B. Soares, R. R. Dos Santos, M. M. Teixeira, and F. Q. Cunha. 2007. Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide. Am. J. Respir. Crit. Care Med. 175: 490-497.
38. Akgul, C., and S. W. Edwards. 2003. Regulation of neutrophil apoptosis via death receptors. Cell Mol. Life Sci. 60: 2402-2408.
39. Neumann, B., N. Zantl, A. Veihelmann, K. Emmanuilidis, K. Pfeffer, C. D. Heidecke, and B. Holzmann. 1999. Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int. Immunol. 11: 217-227.
40. Barthlen, W., N. Zantl, K. Pfeffer, C. D. Heidecke, B. Holzmann, and J. Stadler. 1999. Impact of experimental peritonitis on bone marrow cell function. Surgery 126: 41-47.
41. Rintala, E., H. Peuravuori, K. Pulkki, L. M. Voipio-Pulkki, and T. Nevalainen. 2000. Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome. Intensive Care Med. 26: 1248-1251.
42. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, R. M. Strieter, and S. L. Kunkel. 1999. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 163: 6148-6154.
43. van der Poll, T. 2001. Immunotherapy of sepsis. Lancet Infect Dis. 1: 165-174.
44. Weighardt, H., S. Kaiser-Moore, S. Schlautkotter, T. Rossmann-Bloeck, U. Schleicher, C. Bogdan, and B. Holzmann. 2006. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J. Immunol. 177: 5623-5630. (Pubitemid 44527637)
45. Dear, J. W., H. Yasuda, X. Hu, S. Hieny, P. S. Yuen, S. M. Hewitt, A. Sher, and R. A. Star. 2006. Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int. 69: 832-836.
46. Bone, R. C., W. J. Sibbald, and C. L. Sprung. 1992. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101: 1481-1483.
47. Remick, D. G., and H. Xioa. 2006. Hypothermia and sepsis. Front. Biosci. 11: 1006-1013.
48. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414.
49. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
50. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643-647.
51. Goodman, R. B., R. M. Strieter, D. P. Martin, K. P. Steinberg, J. A. Milberg, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, and T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154: 602-611. (Pubitemid 26327279)
52. Harada, A., N. Sekido, T. Akahoshi, T. Wada, N. Mukaida, and K. Matsushima. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukocyte Biol. 56: 559-564. (Pubitemid 24348812)
53. Bozic, C. R., N. P. Gerard, C. von Uexkull-Guldenband, L. F. Kolakowski, Jr., M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1994. The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J. Biol. Chem. 269: 29355-29358. (Pubitemid 24987927)
54. Cummings, C. J., T. R. Martin, C. W. Frevert, J. M. Quan, V. A. Wong, S. M. Mongovin, T. R. Hagen, K. P. Steinberg, and R. B. Goodman. 1999. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162: 2341-2346.
55. Adams, J. M., C. J. Hauser, D. H. Livingston, R. F. Lavery, Z. Fekete, and E. A. Deitch. 2001. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure. J. Trauma. 51: 452-456; discussion 456-457.
56. Benjamim, C. F., J. S. Silva, Z. B. Fortes, M. A. Oliveira, S. H. Ferreira, and F. Q. Cunha. 2002. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect. Immun. 70: 3602-3610.
57. Sanui, H., S. Yoshida, K. Nomoto, R. Ohhara, and Y. Adachi. 1982. Peritoneal macrophages which phagocytose autologous polymorphonuclear leucocytes in guinea-pigs: I. Induction by irritants and microorgansisms and inhibition by colchicine. Br. J. Exp. Pathol. 63: 278-284. (Pubitemid 12097242)
58. Cox, G., J. Crossley, and Z. Xing. 1995. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am. J. Respir. Cell Mol. Biol. 12: 232-237.
59. Chung, C. S., G. Y. Song, J. Lomas, H. H. Simms, I. H. Chaudry, and A. Ayala. 2003. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J. Leukocyte Biol. 74: 344-351.
60. Hotchkiss, R. S., P. E. Swanson, B. D. Freeman, K. W. Tinsley, J. P. Cobb, G. M. Matuschak, T. G. Buchman, and I. E. Karl. 1999. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27: 1230-1251.
61. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96: 14541-14546.
62. Schroder, J., F. Stuber, H. Gallati, F. U. Schade, and B. Kremer. 1995. Pattern of soluble TNF receptors I and II in sepsis. Infection 23: 143-148.
63. Peng, T., X. Lu, M. Lei, G. W. Moe, and Q. Feng. 2003. Inhibition of p38 MAPK decreases myocardial TNF-α expression and improves myocardial function and survival in endotoxemia. Cardiovasc. Res. 59: 893-900.
64. Arndt, P., and E. Abraham. 2001. Immunological therapy of sepsis: experimental therapies. Intensive Care Med. 27(Suppl. 1): S104-S115.